youth anxiety symptoms

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

CBT showed mixed results compared to placebo at week 12 on parent-reported anxiety: superior on the MASC-P but not statistically different from placebo on the Parent SCARED.

Effect: mixed; b= -7.0, t= -2.9 (MASC-P, superior to PBO); adj p=.26 (SCARED, not superior to PBO)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)

Combination treatment (CBT + sertraline) was superior to placebo at week 12 on parent-reported youth anxiety symptoms across both the MASC-P and Parent SCARED measures.

Effect: improvement; b= -15.7, t= -6.4 (MASC-P); b= -9.8, t= -5.9 (SCARED)